Curocell to retry CAR-T Rimqarto reimbursement in July after first HIRA setback Korea Biomedical Review 02:29 Thu, 28 May
Curocell bets on faster access as Korea’s 1st homegrown CAR-T enters market Korea Biomedical Review 07:00 Thu, 14 May
ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readiness PR Newswire (Press Release) 12:53 Mon, 11 May
Curocell's Rimqarto Inj. Wins Full Regulatory Approval, Poised to Enter car-T Market with 67% Complete Response Rate Business Wire (Press Release) 07:31 Thu, 30 Apr
Curocell’s Rimqarto approval turns Korea’s CAR-T race into a reimbursement battle Korea Biomedical Review 02:14 Thu, 30 Apr
